Insider Transactions Reported by 19 Insiders of Rapport Therapeutics, Inc.

Symbol
RAPP on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Rapport Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures V, L.P. 10%+ Owner $80,882,421 10 Jun 2024
ARCH Venture Partners XII, LLC 10%+ Owner $37,212,805 10 Jun 2024
JAMES HEALY Director $19,916,028 17 Jun 2025
Abraham Ceesay Chief Executive Officer, Director $17,832,879 -$3,176,552 -15% 02 Feb 2026
David Bredt Chief Scientific Officer $10,838,755 -$1,708,614 -14% 02 Feb 2026
Krishnaswamy Yeleswaram Chief Development Officer $8,924,579 -$85,342 -0.95% 02 Feb 2026
Cheryl Gault Chief Operating Officer $5,174,568 -$150,487 -2.8% 02 Feb 2026
Bradley S. Galer Chief Medical Officer $1,970,311 06 Jun 2024
STEVEN M. PAUL Director $416,243 12 Sep 2025
Reid M. Huber Director $203,796 12 Sep 2025
Troy A. Ignelzi Chief Financial Officer $99,800 +$100,988 02 Feb 2026
Wendy B. Young Director $94,905 +$61,250 +182% 11 Sep 2025
Paul M. Silva Director 17 Jun 2025
ROBERT J. PEREZ Director 17 Jun 2025
JOHN MARAGANORE Director 17 Jun 2025
Jeffrey Sevigny Chief Medical Officer 02 Feb 2026
Jeffrey K. Tong Director 06 Jun 2024
Terry-Ann Burrell Director 06 Jun 2024
Ramiro Sanchez Director 17 Jun 2025

Recent Insider Transactions by Companies or Individuals for Rapport Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.